Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Dec 16, 2021
- Accession no.
- 0001209191-21-070104
- Filed
- Dec 16, 2021, 9:25 PM ET
- Trade date
- Dec 16, 2020-Dec 15, 2021
- Filing delay
- 365 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $160.8K. It was filed 365 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, GEN. COUN. & SECRTY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Class A Common Stock | FTax withholdingDisposed | −3,506 | $90.55 | −$317,468.3 | 46,956 | Direct | |
| Dec 15, 2021 | Class A Common Stock | AGrant or awardAcquired | +14,757 | $0.00 | $0 | 61,713 | Direct | |
| Dec 16, 2020 | Class A Common Stock | FTax withholdingDisposed | −1,637 | $91.80 | −$150,276.6 | 60,076 | Direct | |
| Dec 16, 2020 | Class A Common Stock | SSaleDisposed | −1,432 | $90.97F7 | −$130,263.17 | 58,644 | Direct | |
| Dec 16, 2020 | Class A Common Stock | SSaleDisposed | −332 | $91.90F8 | −$30,511.6 | 58,312 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Class A Common Stock | AGrant or awardAcquired | +7,378 | $0.00 | $0 | 7,378 | Direct | |
| Dec 15, 2021 | Class A Common Stock | AGrant or awardAcquired | +30,545 | $0.00 | $0 | 30,545 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F7
The shares were sold in multiple transactions at prices ranging from $90.65 to $91.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F8
The shares were sold in multiple transactions at prices ranging from $91.81 to $92.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.